logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Novel Biomarkers In The Continuum Of Breast Cancer 1st Edition Vered Stearns Eds

  • SKU: BELL-5482654
Novel Biomarkers In The Continuum Of Breast Cancer 1st Edition Vered Stearns Eds
$ 31.00 $ 45.00 (-31%)

4.7

36 reviews

Novel Biomarkers In The Continuum Of Breast Cancer 1st Edition Vered Stearns Eds instant download after payment.

Publisher: Springer International Publishing
File Extension: PDF
File size: 7.5 MB
Pages: 291
Author: Vered Stearns (eds.)
ISBN: 9783319229089, 9783319229096, 3319229087, 3319229095
Language: English
Year: 2016
Edition: 1

Product desciption

Novel Biomarkers In The Continuum Of Breast Cancer 1st Edition Vered Stearns Eds by Vered Stearns (eds.) 9783319229089, 9783319229096, 3319229087, 3319229095 instant download after payment.

This volume provides a comprehensive review of established and novel biomarkers across the continuum of breast cancer. The volume covers topics related to breast cancer risk and prevention, prediction of response to today’s standard therapies, and markers capable of influencing treatment decisions in the near future. Chapter authors combine their wide-ranging expertise to review the current status of the biomarker and to offer their individual perspectives on how biomarkers may be used in future treatments and research.Breast cancer continues to be the most common malignancy diagnosed in women in the Western world. While there are multiple treatment approaches for breast cancer, today more than ever we recognize that each tumor is unique. The challenge ahead is to consider how to best use validated and novel biomarkers to select the most appropriate treatment(s) for individual patients.

Related Products